| Literature DB >> 34070198 |
Cristiano Carbonelli1, Angela de Matthaeis2, Antonio Mirijello2, Concetta Di Micco3, Evaristo Maiello3, Salvatore De Cosmo2, Paolo Graziano4.
Abstract
Clinical manifestations accompanying respiratory failure with insidious and rapidly progressive onset are often non-specific. Symptoms such as a cough, dyspnea, and fever are common to a large number of inflammatory, infectious, or neoplastic diseases. During the COVID-19 pandemic it is essential to limit the use of hospital services and inappropriate diagnostic techniques. A particular radiological pattern can orient the clinical and laboratory scenario and guide the diagnostic workup. A 58-year-old woman was admitted to our COVID-19 unit for suspected coronavirus infection. She was complaining of worsening dyspnea, tachycardia, and low grade fever. A chest X-ray showed diffuse, alveolar, and interstitial lung involvement with micronodules tending to coalescence. This radiographic pattern known as "galaxy sign", consistent with diffuse, coalescing nodular miliary pulmonary involvement, simulating a non-specific alveolar opacification of the lungs is typical of a few pneumological differential diagnoses, represented by sarcoidosis, tuberculosis, pneumoconiosis, and metastatic lesions, and virtually excludes an interstitial viral pneumonitis. The use of endoscopic techniques can, in such cases, confirm the clinical suspicion for initiating appropriate targeted therapies.Entities:
Keywords: interventional pulmonology; lung cancer; metastasis; miliary pulmonary involvement
Year: 2021 PMID: 34070198 PMCID: PMC8158502 DOI: 10.3390/diagnostics11050899
Source DB: PubMed Journal: Diagnostics (Basel) ISSN: 2075-4418
Results of laboratory tests and blood gas analysis.
| Laboratory Tests | Results | Reference Range |
|---|---|---|
| ALT (U/L) | 20.00 | 10–42 |
| AST (U/L) | 24.00 | 8–30 |
| Total bilirubin (mg/dL) | 0.40 | 0.2–1.0 |
| Sodium (mmol/L) | 159.0 | 136–145 |
| Potassium (mmol/L) | 4.9 | 3.5–5.0 |
| Clorum (mmol/L) | 125.0 | 98–107 |
| Creatinine (mg/dL) | 0.50 | 0.55–1.02 |
| Urea (mg/dL) | 30.0 | 15–38 |
| Glycemia (mg/dL) | 92.0 | 70–100 |
| Total protein (g/dL) | 6.30 | 6.4–8.2 |
| C-reactive protein (mg/dL) | <0.290 | <0.30 |
| Erythrocyte sedimentation rate (mm) | 45 | 2–15 |
| Procalcitonin (µ/L) | 0.09 | <0.50 |
| Hemoglobin (g/dL) | 14.1 | 12–16 |
| Mean corpuscular volume (FL) | 87 | 77–98 |
| Red blood cells (103/mm3) | 5080 | 4200–5400 |
| White blood cells (/mm3) | 20,650 | 4300–10,800 |
| Neutrophilis (%) | 94.6 | 40–80 |
| Lymphocytes (%) | 3.5 | 10–45 |
| Monocytes (%) | 1.3 | 2.0–10.0 |
| Basophils (%) | 0.00 | <1.50 |
| Eosinophils (%) | 0.4 | 0.3–7.0 |
| Platelets (103/mm3) | 481 | 130–400 |
| Fibrinogen (mg/dL) | 669 | 150–400 |
| INR (Ratio) | 1.03 | 0.80–1.20 |
| pH | 7.44 | 7.35–7.45 |
| PCO2 (mmHg) | 31.5 | 35.0–45.0 |
| PO2 (mmHg) | 52.9 | 80.0–100.0 |
| HCO3 (mmol/L) | 21.9 | 22.0–26.0 |
| Lactate (mmol/L) | 0.9 | 0.5–1.6 |
| SpO2 (%) | 91.2 | 90–99 |
Figure 1Chest radiograph showing a diffuse, alveolar and interstitial lung involvement with coalescing micronodules, simulating a non-specific alveolar opacification of the lungs (galaxy sign) (R: right side).
Figure 2High power (21x) hematoxylin and eosin view of a bronchoscopic transbronchial pulmonary sample in the same patient, showing primary lung adenocarcinoma with lepidic non mucinous and acinar patterns.